Form 8-K - Current report:
SEC Accession No. 0001193805-26-000516
Filing Date
2026-04-28
Accepted
2026-04-28 07:00:28
Documents
15
Period of Report
2026-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e665394_8k-immunic.htm   iXBRL 8-K 36807
2 e665394_ex10-1.htm EX-10.1 113615
3 e665394_ex10-2.htm EX-10.2 44219
4 e665394_ex99-1.htm EX-99.1 20539
8 GRAPHIC image1.jpg GRAPHIC 4723
  Complete submission text file 0001193805-26-000516.txt   440603

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE imux-20260424.xsd EX-101.SCH 3002
6 XBRL LABEL FILE imux-20260424_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE imux-20260424_pre.xml EX-101.PRE 22350
18 EXTRACTED XBRL INSTANCE DOCUMENT e665394_8k-immunic_htm.xml XML 3313
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 26903070
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)